Oklahoma U.S. Rep Kevin Hern: “Learn more about the Congressional art competition at hern.house.gov! The submission deadline for…”

Oklahoma U.S. Rep Kevin Hern: “Learn more about the Congressional art competition at hern.house.gov! The submission deadline for…”
0Comments

Kevin Hern tweeted the following:

“Learn more about the Congressional art competition at hern.house.gov!
The submission deadline for students in the 1st District is April 8th. twitter.com/okartscouncil/
Read on Twitter

Here are other recent tweets from Kevin Hern:

“Banning Russian oil is only part of it we need to unshackle AMERICAN energy producers! twitter.com/jakesherman/st” on March 3
Read on Twitter
“Oklahoma and other energy producing states are more than capable of exceeding our reliance on Russian oil. Why do we continue to rely on Russia when the answer is right here in our backyard? twitter.com/HouseGOP/statu” on March 3
Read on Twitter
“The State of our Union is a total disaster. Biden’s speech last night was full of hypocrisy – the few applause lines he had were all for Trump programs he ended.
I shared my thoughts and reaction to his speech on @newsmax this afternoon, watch here –>” on March 2
Read on Twitter



Related

Caleb Michaud, Acting Associate Commissioner for External Affairs of FDA

FDA conducted inspections of 40 companies in cities located in Rogers County in 2025

There were 40 companies in cities associated with Rogers County that received 40 FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Sara Brenner, Principal Deputy Commissioner at FDA

43 companies in cities within Tulsa County received 43 inspections in 2025

There were 43 companies in cities associated with Tulsa County that received 43 FDA inspections in 2025, according to the U.S. Food and Drug Administration.

Sean R. Keveney J.D., Chief Counsel of FDA

Cities located in Osage County saw FDA inspections of 39 companies in 2025

There were 39 companies in cities associated with Osage County that received 39 FDA inspections in 2025, according to the U.S. Food and Drug Administration.